Debiovision News
Most Popular Debiovision Story
FDA experts turn thumbs down on Debiovision drug
An FDA advisory panel unanimously decided to show Debiovision the door after deciding that an experimental drug it was proposing lacked the data it needed to prove the therapy stopped esophageal Read more...
Latest Headlines
- May 20, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
